Clinical Trials Browser

Phase 2 × Brain Neoplasms × Palonosetron × Clear all

NCT00636805 2014-04-01

Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab

Phase 2 Terminated

63 enrolled 11 charts

Brain Neoplasms